Search filters
Filters
Clear All

Phase

  • 59
  • 97
  • 108
  • 89
  • 14
  • 170
  • 696
  • 449
  • 14
  • 31
  • 1
  • 4
  • 648

Found 698 none trials

A listing of none medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sub-study of L-RAD (832203): Collection of Tissue and Fluid Samples for Research in Lymphoproliferative Disorders

99 years or below
All genders
To support the research of lymphoproliferative disorders (LPDs) by supplementing the main repository (IRB #832203) with biospecimens (i.e., tissue and fluid) obtained solely for the purpose of research. These materials will be used for future, unspecified research.
Learn More

CARDIOVASCULAR PULMONARY AND RENAL PHENOTYPES IN COVID-19 SURVIVORS

99 years or below
All genders
In this study, the Investigator at the University of Pennsylvania will assess organ-specific biomarker profiles (proteins and metabolites), in order to better understand biologic processes, the interplay between the heart and extracardiac organs, and their role in human disease, with an emphasis on cardiovascular disease. The study will specifically focus …
Learn More

Lymph Node Fine Needle Aspiration to Study Immune Responses to Vaccinations

99 years or below
All genders
The purpose of this study is to obtain lymph node samples to understand how the immune system makes a response to vaccinations. In particular, we will study the immune cells within lymph nodes, where we think important parts of the vaccine response occur. We believe that if we study only …
Learn More

A phase II open-label study of ONC201 in adults with recurrent high-grade glioma

99 years or below
All genders
Phase 2
This is A phase II, open-label study of ONC201 in adults with recurrent high- grade glioma. Subjects will be age 18 or older with a histone H3 K27M mutant glioma that has progressed after radiation therapy. The primary objective is to estimate the overall response rate (ORR) of ONC201 in …
Learn More

An open-label multi-center roll-over study to assess long

99 years or below
All genders
Phase 3
The purpose is to evaluate the long-term safety of osilodrostat in patients who have already received osilodrostat treatment in a previous Novartis trial for treatment of Cushing's syndrome.
Learn More

Substudy: Understanding COVID-19 vaccine responses in the setting of immunotherapy

99 years or below
All genders
Since its emergence, SARS-Cov2 has rapidly and widely spread across the globe due to lack of prior protective immunity in the human species. With widespread mitigation measures, all efforts focused on generating effective vaccination strategies that will provide herd immunity and protect the most vulnerable populations. However, there is very …
Learn More

Treatment for Mixed Urinary Incontinence: Mid-urethral Sling vs. Botox A

99 years or below
All genders
ABSTRACT Mixed urinary incontinence (MUI), defined as the presence of both stress urinary incontinence and urgency urinary incontinence, is a challenging condition for which clinicians frequently use multiple sequential treatments that have undergone limited head to head comparison in rigorous clinical trials. Mid-urethral Sling vs. Botox A (MUSA) is a …
Learn More

RADVAX FOR RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA: A PHASE II TRIAL OF PEMBROLIZUMAB + LOW DOSE RADIOTHERAPY

99 years or below
All genders
Phase 2
We plan to treat subjects with pembrolizumab in combination with radiation therapy to see if the combination is an effective treatment for relapsed/refractory non-Hodgkin lymphoma.
Learn More

Spironolactone for Regulating Blood Pressure after Intracerebral Hemorrhage

99 years or below
All genders
The purpose of this research study is to determine whether blood pressure treatment regimens with spironolactone are better than blood pressure treatment regimens without spironolactone at lowering blood pressure in hemorrhagic Stroke survivors. This study will randomize a total of 200 patients, 100 of each white and nonwhite patients, between …
Learn More

Early diagnosis of transthyretin cardiac amyloidosis

99 years or below
All genders
Disease modifying therapies for ATTR transthyretin cardiac amyloidosis (ATTR-CA) promises to make a previously untreatable disease manageable. In general, cardiac amyloidosis of any type has been shown to be underdiagnosed or diagnosed late in the disease process. Our goal of the study is to identify African American (AA) patients who …
Learn More
131 - 140 of 698